COMPARATIVE IMMUNOHISTOCHEMICAL EVALUATION OF E-CADHERIN AND Β-KATENIN EXPRESSION IN METASTATIC AND NON-METASTATIC BREAST CANCER OF NON-SPECIFIC TYPE

Objective: an immunohistochemical analysis of the features of expression, distribution and interaction of E-сadherin and β-сatenin proteins in primary mammary tumors.

Materials and methods. The study group consisted of 148 relevant patients with breast cancer (BC), including patients with metastases in lymph nodes (n = 12) and liver (n = 45). E-сadherin and β-сatenin expression on BC cells was determined using immunohistochemical method with specific antibodies.

Results. It was shown that the reduction and the total absence of E-сadherin expression was observed much more often in patients with BC with metastases in liver, than in patients without metastases (70 % of cases versus 30 % of cases respectively). An increase of cytoplasmic immune reactivity and a nuclear translocation of β-сatenin are found in more than 80 % cases of BC with metastases.

Conclusion. The changes in the expression of E-сadherin and β-сatenin in tumor cell can be considered as factors of a non-favorable prognosis of BC. The emergence of β-сatenin expression indicates the activation of a signaling pathway which is triggered by the aberrant expression of epithelial cadherins leading to an increased mobility and invasion of tumor cells.

1. Мнихович М.В. Межклеточные и клеточно-матриксные взаимодействия в опухолях: современное состояние проблемы. Российский медико-биологический вестник им. aкад. И.П. Павлова 2013;3:161–71. [Mnikhovich M.V. Intercellular and cell-extracellular matrix interactions: current concept. Rossiyskiy mediko-biologicheskiy vestnik im. akad. I.P. Pavlova = I.P. Pavlov Russian Medical Biological Bulletin 2013;3:161–71. (In Russ.)].

2. Zasadkevich Yu.M., Brilliant A.A., Sazonov S.V. Сharacteristics of the relation between epithelial-mesenchimal transition and proliferative activity in breast carcinomas. Eur J Cancer 2013;49(1):216.

3. Мнихович М.В., Вернигородский С.В., Буньков К.В. Эпителиально-мезенхимный переход, трансдифференциация, репрограммирование и метаплазия: современный взгляд на проблему. Морфологические ведомости 2017;25(3):14–21. [Mnikhovich M.V., Vernigorodskiy S.V, Bun’kov K.V. Epithelial-mesenchymal transition, transdifferentiation, reprogramming and metaplasia: current concept. Morfologicheskie vedomosti = Morphological Newsletter 2017;25(3):14–21. (In Russ.)].

4. Kildal W., Risberg B., Abeler V.M. et al. Beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. Eur J Cancer 2005;41(8):1127–34. PMID: 15911235. DOI: 10.1016/j.ejca.2005.01.022.

5. Bernard P., Fleming A., Lacombe A. et al. Wnt4 inhibits b-catenin/TCF signalling by redirecting b-catenin to the cell membrane. Biol Cell 2008;100(3):167–77. PMID: 17976036. DOI: 10.1042/ BC20070072.

6. Sparks A.B., Morin P.J., Vogelstein B., Kinzler K.W. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58(6):1130–4. PMID: 9515795.

7. Berx G., Van Roy F. The E-cadherin/ catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001;3(5):289–93. PMID: 11597316.

8. Mayer B., Johnson J.P., Leitl F. et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53(7):1690–5. PMID: 8453643.

9. Frixen U.H., Behrens J., Sachs M. et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113(1):173–85. PMID: 2007622.

10. Сазонов С.В., Засадкевич Ю.М., Бриллиант А.А. и др. Роль эпителиальных Е- и Р-кадгеринов, а также β- и р120- катенинов в функционировании молочной железы. Вестник Уральской медицинской академической науки 2015;55(4):67–70. [Sazonov S.V., Zasadkevich Yu.M., Brilliant A.A. et al. Role of epithelial E-and P-cadherins and β- and P120-catenins in the breast functioning. Vestnik Uralskoy meditsinskoy akademicheskoy nauki = Journal of Ural Medical Academic Science 2015;55(4):67–70. (In Russ.)].

11. Глушанкова Н.А., Житняк И.Ю., Айолло Д.В., Рубцова С.Н. Роль Е-кадгерина в неопластической эволюции эпителиальных клеток. Успехи современной онкологии 2014;1:12–7. [Glushankova N.A., Zhitnyak I.Yu., Ayollo D.V., Rubtsova S.N. Role of E-cadherin in neoplastic evolution of epithelial cells. Uspekhi sovremennoy onkologii = Advances in Oncology 2014;1:12–7. (In Russ.)].

12. Imai T., Horiuchi A., Shiozawa T. et al. Elevated expression of E-cadherin and alpha-, beta- and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 2004;35(12):1469–76.

13. Засадкевич Ю.М., Бриллиант А.А., Сазонов С.В. Особенности экспрессии маркеров эпителиально-мезенхимального перехода E-кадгерина и виментина при разных иммуногистохимических вариантах карциномы молочной железы. Уральский медицинский журнал 2014;116(2):29–32. [Zasadkevich Yu.M., Brilliant A.A., Sazonov S.V. Expression of epithelial-mesenchymal transition markers E-cadherin and vimentin in different immunohistochemical variants of breast carcinoma. Uralskiy meditsinskiy zhurnal = Ural Medical Journal 2014;116(2):29–32. (In Russ.)].

14. Ayollo D.V., Zhitnyak I.Y., Vasiliev J.M. et al. Rearrangements of the actin cytoskeleton and E-cadherin-based adherens junctions caused by neoplasic transformation change cell–cell interactions. PLoS One 2009;4(11):e8027. PMID: 19956566. DOI: 10.1371/journal.pone.0008027.

15. Mnikhovich М., Kaktursky L., Zagrebin V. et al. Changes in expression of membraneassociated proteins connected to epithelial-mesenchimal transition during breast cancer progression. Virchows Arch 2017;471(Suppl 1):S66.

16. Перельмутер В.М., Завьялова М.В., Вторушин С.В. и др. Взаимосвязь морфологической гетерогенности инфильтрирующего протокового рака молочной железы с различными формами опухолевой прогрессии. Сибирский онкологический журнал 2007;3:58–64. [Perel’muter V.M., Zavyalova M.V., Vtorushin S.V. et al. Correlation between morphological heterogeneity of infiltrating ductal carcinoma of the breast and various forms of tumor progression. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2007;3:58–64. (In Russ.)].

17. Сазонов С.В., Конышев К.В., Казанцева Н.В. и др. Гистологические и иммуногистохимические проявления эпителио-мезенхимального перехода при тройном негативном раке молочной железы. Вестник Уральской медицинской академической науки 2016;2: 53–63. [Sazonov S.V., Konyshev K.V., Kazantseva N.V. et al. Histological and immunohistochemical characteristics of epithelial-mesenchymal transition in triple negative breast cancer. Vestnik Uralskoy meditsinskoy akademicheskoy nauki = Journal of Ural Medical Academic Science 2016;2:53–63. (In Russ.)].